References
- US FDA. Tissue agnostic drug development in oncology: draft guidance for industry [accessed on November 20, 2023]. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/tissue-agnostic-drug-development-oncology
- Kim N, Lee ES, Won SE, Yang M, Lee AJ, Shin Y, et al. Evolution of radiological treatment response assessments for cancer immunotherapy: from iRECIST to radiomics and artificial intelligence. Korean J Radiol 2022;23:1089-1101 https://doi.org/10.3348/kjr.2022.0225
- Xiao L, Yu S, Xu W, Sun Y, Xin J. (99m)Tc-3PRGD(2) SPECT/CT imaging for diagnosing lymph node metastasis of primary malignant lung tumors. Korean J Radiol 2023;24:1142-1150 https://doi.org/10.3348/kjr.2023.0411
- Woo C, Jo KH, Sohn B, Park K, Cho H, Kang WJ, et al. Development and testing of a machine learning model using (18)F-fluorodeoxyglucose PET/CT-derived metabolic parameters to classify human papillomavirus status in oropharyngeal squamous carcinoma. Korean J Radiol 2023;24:51-61 https://doi.org/10.3348/kjr.2022.0397
- Wang Y, Gao F. Research progress of CXCR4-targeting radioligands for oncologic imaging. Korean J Radiol 2023;24:871-889 https://doi.org/10.3348/kjr.2023.0091
- Cheng L, Yang T, Zhang J, Gao F, Yang L, Tao W. The application of radiolabeled targeted molecular probes for the diagnosis and treatment of prostate cancer. Korean J Radiol 2023;24:574-589 https://doi.org/10.3348/kjr.2022.1002
- Yang X, Lu X, Liu J, Kan Y, Wang W, Zhang S, et al. Development and validation of (18)F-FDG PET/CT-based multivariable clinical prediction models for the identification of malignancy-associated hemophagocytic lymphohistiocytosis. Korean J Radiol 2022;23:466-478 https://doi.org/10.3348/kjr.2021.0733
- Li S, Li Y, Zhao M, Wang P, Xin J. Combination of (18) F-fluorodeoxyglucose PET/CT radiomics and clinical features for predicting epidermal growth factor receptor mutations in lung adenocarcinoma. Korean J Radiol 2022;23:921-930 https://doi.org/10.3348/kjr.2022.0295
- Futterer JJ, Nagarajah J. Research highlight: (68)Ga-PSMA-11 PET imaging for pelvic nodal metastasis in prostate cancer. Korean J Radiol 2022;23:293-294 https://doi.org/10.3348/kjr.2021.0938
- Bu L, Tu N, Wang K, Zhou Y, Xie X, Han X, et al. Relationship between (18)F-FDG PET/CT semi-quantitative parameters and international association for the study of lung cancer, american thoracic society/european respiratory society classification in lung adenocarcinomas. Korean J Radiol 2022;23:112-123 https://doi.org/10.3348/kjr.2021.0455